{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:37:48Z","timestamp":1787063868363,"version":"build-2736575974"},"reference-count":101,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2002,11,1]],"date-time":"2002-11-01T00:00:00Z","timestamp":1036108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2002,11]]},"DOI":"10.1053\/ajkd.2002.36332","type":"journal-article","created":{"date-parts":[[2002,10,29]],"date-time":"2002-10-29T16:06:25Z","timestamp":1035907585000},"page":"886-898","source":"Crossref","is-referenced-by-count":26,"title":["Preventing bacterial infections and antimicrobial resistance in dialysis patients"],"prefix":"10.1053","volume":"40","author":[{"given":"Jeffrey S.","family":"Berns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome I.","family":"Tokars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/ajkd.2002.36332_bib1","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJM199611073351907","article-title":"Antimicrobial-drug resistance","volume":"335","author":"Gold","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1053\/ajkd.2002.36332_bib2","doi-asserted-by":"crossref","first-page":"N64","DOI":"10.1097\/00003246-200104001-00002","article-title":"Increasing prevalence of antimicrobial resistance in intensive care units","volume":"29","author":"Fridkin","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1053\/ajkd.2002.36332_bib3","first-page":"2","article-title":"Recommendations for preventing transmission of infections among hemodialysis patients","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"MMWR Morbid Mortal Wkly Rep"},{"key":"10.1053\/ajkd.2002.36332_bib4","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1046\/j.1525-139X.2002.00051.x","article-title":"National Surveillance of Dialysis-Associated Diseases in the United States, 2000","volume":"15","author":"Tokars","year":"2002","journal-title":"Semin Dial"},{"key":"10.1053\/ajkd.2002.36332_bib5","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1053\/ajkd.2000.19103","article-title":"Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998","volume":"36","author":"Zelenitsky","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.36332_bib6","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/ki.1993.191","article-title":"Methicillin-resistant Staphylococcus aureus nasal carriage and infections in CAPD","volume":"43","author":"Lye","year":"1993","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2002.36332_bib7","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0272-6386(12)80569-5","article-title":"Methicillin-resistant staphylococcal infections in an outpatient peritoneal dialysis program","volume":"16","author":"Holley","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.36332_bib8","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJM199902183400701","article-title":"Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group","volume":"340","author":"Smith","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1053\/ajkd.2002.36332_bib9","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1086\/317542","article-title":"Vancomycin-intermediate and -resistant Staphylococcus aureus: What the infectious disease specialist needs to know","volume":"32","author":"Fridkin","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1053\/ajkd.2002.36332_bib10","first-page":"565","article-title":"Staphylococcus aureus resistant to vancomycin\u2014United States","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"MMWR Morbid Mortal Wkly Rep"},{"key":"10.1053\/ajkd.2002.36332_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/089686089701700121","article-title":"Treatment in PD patients of peritonitis caused by gram-positive organisms with single daily dose of antibiotics","volume":"17","author":"Vas","year":"1997","journal-title":"Perit Dial Int"},{"key":"10.1053\/ajkd.2002.36332_bib12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/089686089901900406","article-title":"Challenges of managing chronic peritoneal dialysis-associated peritonitis","volume":"19","author":"Troidle","year":"1999","journal-title":"Perit Dial Int"},{"key":"10.1053\/ajkd.2002.36332_bib13","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1056\/NEJM198704093161507","article-title":"Emergence of vancomycin resistance in coagulase-negative staphylococci","volume":"316","author":"Schwalbe","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1053\/ajkd.2002.36332_bib14","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJM200003093421007","article-title":"Vancomycin-resistant enterococcal infections","volume":"342","author":"Murray","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/ajkd.2002.36332_bib15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1017\/S0950268800030478","article-title":"High-level vancomycin-resistant enterococci causing hospital infections","volume":"103","author":"Uttley","year":"1989","journal-title":"Epidemiol Infect"},{"key":"10.1053\/ajkd.2002.36332_bib16","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1053\/ajkd.1998.v32.pm9708609","article-title":"Colonization with vancomycin-resistant enterococci in chronic hemodialysis patients","volume":"32","author":"Roghmann","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.36332_bib17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1053\/ajkd.1998.v32.pm9740157","article-title":"Vancomycin-resistant enterococcus in end-stage renal disease","volume":"32","author":"Brady","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.36332_bib18","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1046\/j.1523-1755.2001.059002718.x","article-title":"Outpatient vancomycin use and vancomycin-resistant enterococcal colonization in maintenance dialysis patients","volume":"59","author":"Atta","year":"2001","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2002.36332_bib19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1086\/503139","article-title":"Vancomycin-resistant enterococci in hemodialysis patients is related to intravenous vancomycin use","volume":"20","author":"Fishbane","year":"1999","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1053\/ajkd.2002.36332_bib20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1086\/317549","article-title":"Vancomycin-resistant enterococci among chronic hemodialysis patients: A prospective study of acquisition","volume":"32","author":"D'Agata","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1053\/ajkd.2002.36332_bib21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/089686089901900316","article-title":"Vancomycin-resistant enterococcus infection is a rare complication in patients receiving PD on an outpatient basis","volume":"19","author":"Ng","year":"1999","journal-title":"Perit Dial Int"},{"key":"10.1053\/ajkd.2002.36332_bib22","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1038\/ki.1996.451","article-title":"Nine episodes of CPD-associated peritonitis with vancomycin resistant enterococci","volume":"50","author":"Troidle","year":"1996","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2002.36332_bib23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1525-139X.1999.99051.x","article-title":"Peritonitis due to vancomycin-resistant enterococci: A case report and review of the literature","volume":"12","author":"Carey","year":"1999","journal-title":"Semin Dial"},{"key":"10.1053\/ajkd.2002.36332_bib24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00002480-197700230-00012","article-title":"Incidence and type of infections occurring in 445 chronic hemodialysis patients","volume":"23","author":"Keane","year":"1977","journal-title":"Trans Am Soc Artif Intern Organs"},{"key":"10.1053\/ajkd.2002.36332_bib25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1525-139x.2000.00029.x","article-title":"Vaccine recommendations for patients on chronic dialysis. The Advisory Committee on Immunization Practices and the American Academy of Pediatrics","volume":"13","author":"Rangel","year":"2000","journal-title":"Semin Dial"},{"key":"10.1053\/ajkd.2002.36332_bib26","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2307\/30142429","article-title":"Guideline for infection control in healthcare personnel, 1998. Hospital Infection Control Practices Advisory Committee","volume":"19","author":"Bolyard","year":"1998","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1053\/ajkd.2002.36332_bib27","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMoa011297","article-title":"Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis","volume":"346","author":"Shinefield","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1053\/ajkd.2002.36332_bib28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM200101043440102","article-title":"Nasal carriage as a source of Staphylococcus aureus bacteremia","volume":"344","author":"von Eiff","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1053\/ajkd.2002.36332_bib29","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1525-139X.1995.tb00387.x","article-title":"Nasal carriage of Staphyloccus aureus in dialysis patients","volume":"8","author":"Bargman","year":"1995","journal-title":"Semin Dial"},{"key":"10.1053\/ajkd.2002.36332_bib30","first-page":"235","article-title":"Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients","volume":"8","author":"Boelaert","year":"1993","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2002.36332_bib31","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2307\/30141172","article-title":"Elimination of nasal carriage of Staphylococcus aureus in hemodialysis patients","volume":"17","author":"Kluytmans","year":"1996","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1053\/ajkd.2002.36332_bib32","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0272-6386(12)80434-3","article-title":"Treatment of Staphylococcus aureus nasal carriers in continuous ambulatory peritoneal dialysis with mupirocin: Long-term results","volume":"22","author":"Perez-Fontan","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.36332_bib33","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1681\/ASN.V7112403","article-title":"Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis","volume":"7","author":"The Mupirocin Study Group","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2002.36332_bib34","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1086\/501575","article-title":"\u201cPulse\u201d nasal mupirocin maintenance regimen in patients undergoing continuous ambulatory peritoneal dialysis","volume":"20","author":"Mylotte","year":"1999","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1053\/ajkd.2002.36332_bib35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1525-139X.1997.tb00473.x","article-title":"Nasal mupirocin: Its role in dialysis patients","volume":"10","author":"Piraino","year":"1997","journal-title":"Semin Dial"},{"key":"10.1053\/ajkd.2002.36332_bib36","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM198607103150204","article-title":"Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis","volume":"315","author":"Yu","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1053\/ajkd.2002.36332_bib37","doi-asserted-by":"crossref","first-page":"811","DOI":"10.2307\/30141176","article-title":"Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment","volume":"17","author":"Miller","year":"1996","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1053\/ajkd.2002.36332_bib38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/089686089801800102","article-title":"Peritoneal catheters and exit-site practices toward optimum peritoneal access: 1998 Update. (Official report from the International Society for Peritoneal Dialysis)","volume":"18","author":"Gokal","year":"1998","journal-title":"Perit Dial Int"},{"key":"10.1053\/ajkd.2002.36332_bib39","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1177\/089686080002000406","article-title":"Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 Update","volume":"20","author":"Keane","year":"2000","journal-title":"Perit Dial Int"},{"key":"10.1053\/ajkd.2002.36332_bib40","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1086\/320001","article-title":"Guidelines for the management of intravascular catheter-related infections","volume":"32","author":"Mermel","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1053\/ajkd.2002.36332_bib41","first-page":"1","article-title":"Guidelines for the prevention of intravascular catheter-related infections","volume":"51","author":"O'Grady","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"suppl 1","key":"10.1053\/ajkd.2002.36332_bib42","first-page":"S137","article-title":"K\/DOQI Clinical Practice Guideline for Vascular Access, 2000","volume":"37","author":"National Kidney Foundation","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.36332_bib43","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1046\/j.1523-1755.1999.0550031081.x","article-title":"Septicemia in dialysis patients: Incidence, risk factors, and prognosis","volume":"55","author":"Powe","year":"1999","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2002.36332_bib44","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1681\/ASN.V95869","article-title":"EPIBACDIAL: A multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients","volume":"9","author":"Hoen","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2002.36332_bib45","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1046\/j.1523-1755.2000.00439.x","article-title":"Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use: A prospective study","volume":"58","author":"Oliver","year":"2000","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2002.36332_bib46","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/ndt\/14.7.1710","article-title":"Outcome and complications of temporary haemodialysis catheters","volume":"14","author":"Kairaitis","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2002.36332_bib47","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1067\/mic.2002.120904","article-title":"New national surveillance system for hemodialysis-associated infections: Initial results","volume":"30","author":"Tokars","year":"2002","journal-title":"Am J Infect Control"},{"key":"10.1053\/ajkd.2002.36332_bib48","doi-asserted-by":"crossref","first-page":"391","DOI":"10.7326\/0003-4819-132-5-200003070-00009","article-title":"Prevention of intravascular catheter-related infections","volume":"132","author":"Mermel","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1053\/ajkd.2002.36332_bib49","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3201\/eid0702.010208","article-title":"New technologies to prevent intravascular catheter-related bloodstream infections","volume":"7","author":"Mermel","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1053\/ajkd.2002.36332_bib50","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2307\/30145574","article-title":"Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion","volume":"15","author":"Raad","year":"1994","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1053\/ajkd.2002.36332_bib51","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/ki.1991.297","article-title":"Prevention of hemodialysis subclavian vein catheter infections by topical povidone-iodine","volume":"40","author":"Levin","year":"1991","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2002.36332_bib52","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1681\/ASN.V961085","article-title":"Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: Effect of mupirocin ointment","volume":"9","author":"Sesso","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2002.36332_bib53","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0195-6701(95)90065-9","article-title":"Mupirocin resistance in coagulase-negative staphylococci, after topical prophylaxis for the reduction of colonization of central venous catheters","volume":"31","author":"Zakrzewska-Bode","year":"1995","journal-title":"J Hosp Infect"},{"key":"10.1053\/ajkd.2002.36332_bib54","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/089686089701700427","article-title":"Unusual complications of a polyurethane PD catheter","volume":"17","author":"Rao","year":"1997","journal-title":"Perit Dial Int"},{"key":"10.1053\/ajkd.2002.36332_bib55","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/ndt\/13.7.1870","article-title":"Spontaneous rupture of polyurethane peritoneal catheter. A possible deleterious effect of mupirocin ointment","volume":"13","author":"Riu","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2002.36332_bib56","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0272-6386(96)90502-8","article-title":"Risk factors for peritonitis in long-term peritoneal dialysis: The Network 9 peritonitis and catheter survival studies. Academic Subcommittee of the Steering Committee of the Network 9 Peritonitis and Catheter Survival Studies","volume":"28","author":"Golper","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.36332_bib57","first-page":"261","article-title":"Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site","volume":"18","author":"Thodis","year":"1998","journal-title":"Perit Dial Int"},{"key":"10.1053\/ajkd.2002.36332_bib58","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0272-6386(96)90105-5","article-title":"A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: Mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin","volume":"27","author":"Bernardini","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.36332_bib59","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1177\/089686080002000512","article-title":"Application of mupirocin cream at the catheter exit site reduces exit-site infections and peritonitis in peritoneal dialysis patients","volume":"20","author":"Casey","year":"2000","journal-title":"Perit Dial Int"},{"key":"10.1053\/ajkd.2002.36332_bib60","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0272-6386(96)90500-4","article-title":"Peritonitis associated with exit site and tunnel infections","volume":"28","author":"Gupta","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.36332_bib61","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1177\/089686080102100604","article-title":"Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection","volume":"21","author":"Annigeri","year":"2001","journal-title":"Perit Dial Int"},{"key":"10.1053\/ajkd.2002.36332_bib62","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/ajkd.2002.30553","article-title":"Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis","volume":"39","author":"Perez-Fontan","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.36332_bib63","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1086\/513766","article-title":"Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the prevention of antimicrobial resistance in hospitals","volume":"25","author":"Shlaes","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1053\/ajkd.2002.36332_bib64","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1086\/520308","article-title":"Practice guidelines for evaluating new fever in critically ill adult patients. Task Force of the Society of Critical Care Medicine and the Infectious Diseases Society of America","volume":"26","author":"O'Grady","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1053\/ajkd.2002.36332_bib65","doi-asserted-by":"crossref","first-page":"641","DOI":"10.7326\/0003-4819-131-9-199911020-00002","article-title":"Clinical utility of blood cultures drawn from indwelling central venous catheters in hospitalized patients with cancer","volume":"131","author":"DesJardin","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1053\/ajkd.2002.36332_bib66","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/clinids\/15.2.197","article-title":"Infectious complications of indwelling vascular catheters","volume":"15","author":"Raad","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1053\/ajkd.2002.36332_bib67","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/ndt\/12.6.1284","article-title":"Current approach to exit-site infections in patients on peritoneal dialysis","volume":"12","author":"Twardowski","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2002.36332_bib68","doi-asserted-by":"crossref","first-page":"298","DOI":"10.7326\/0003-4819-134-4-200102200-00014","article-title":"Antibiotic resistance in the intensive care unit","volume":"134","author":"Kollef","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1053\/ajkd.2002.36332_bib69","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0272-6386(00)70303-9","article-title":"Vancomycin prescribing practices in hospitalized chronic hemodialysis patients","volume":"35","author":"Green","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.36332_bib70","first-page":"1","article-title":"Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC)","volume":"44","author":"Centers for Disease Control and Prevention","year":"1995","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1053\/ajkd.2002.36332_bib71","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1525-139X.1996.tb00659.x","article-title":"Should vancomycin use in dialysis patients be restricted?","volume":"9","author":"Strausbaugh","year":"1996","journal-title":"Semin Dial"},{"key":"10.1053\/ajkd.2002.36332_bib72","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1053\/ajkd.1998.v32.pm9740156","article-title":"Cefazolin as empiric therapy in hemodialysis-related infections: Efficacy and blood concentrations","volume":"32","author":"Marx","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.36332_bib73","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1053\/ajkd.1998.v32.pm9740155","article-title":"Cefazolin in chronic hemodialysis patients: A safe, effective alternative to vancomycin","volume":"32","author":"Fogel","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.36332_bib74","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1093\/ndt\/14.8.2050","article-title":"Cefazolin serum concentrations with fixed intravenous dosing in patients on chronic hemodialysis treatment","volume":"14","author":"Kuypers","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2002.36332_bib75","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0272-6386(01)80126-8","article-title":"Cefazolin dialytic clearance by high-efficiency and high-flux hemodialyzers","volume":"37","author":"Sowinski","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.36332_bib76","first-page":"45","volume":"42","year":"2000","journal-title":"Med Lett Drugs Ther"},{"key":"10.1053\/ajkd.2002.36332_bib77","first-page":"109","volume":"41","year":"1999","journal-title":"Med Lett Drugs Ther"},{"key":"10.1053\/ajkd.2002.36332_bib78","doi-asserted-by":"crossref","first-page":"E20","DOI":"10.1053\/ajkd.2001.27729","article-title":"Linezolid for treatment of vancomycin-resistant enterococcal peritonitis","volume":"38","author":"Bailey","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.36332_bib79","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0140-6736(94)91687-X","article-title":"Treatment of CAPD-peritonitis due to glycopeptide-resistant Enterococcus faecium with quinupristin\/dalfopristin","volume":"344","author":"Lynn","year":"1994","journal-title":"Lancet"},{"key":"10.1053\/ajkd.2002.36332_bib80","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1086\/313897","article-title":"Successful treatment of vertebral osteomyelitis with linezolid in a patient receiving hemodialysis and with persistent methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus bacteremias","volume":"31","author":"Melzer","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1053\/ajkd.2002.36332_bib81","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/clinids\/24.1.90","article-title":"Emergence of increased resistance to quinupristin\/dalfopristin during therapy for Enterococcus faecium bacteremia","volume":"24","author":"Chow","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1053\/ajkd.2002.36332_bib82","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(00)04376-2","article-title":"Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid","volume":"357","author":"Gonzales","year":"2001","journal-title":"Lancet"},{"key":"10.1053\/ajkd.2002.36332_bib83","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0140-6736(01)05410-1","article-title":"Linezolid resistance in a clinical isolate of Staphylococcus aureus","volume":"358","author":"Tsiodras","year":"2001","journal-title":"Lancet"},{"key":"10.1053\/ajkd.2002.36332_bib84","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2307\/30145558","article-title":"Quality standard for antimicrobial prophylaxis in surgical procedures. The Infectious Diseases Society of America","volume":"15","author":"Dellinger","year":"1994","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1053\/ajkd.2002.36332_bib85","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1053\/ajkd.2000.19104","article-title":"Role of preoperative antibiotic prophylaxis in preventing postoperative peritonitis in newly placed peritoneal dialysis catheters","volume":"36","author":"Gadallah","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.36332_bib86","doi-asserted-by":"crossref","first-page":"275","DOI":"10.7326\/0003-4819-127-4-199708150-00003","article-title":"Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis","volume":"127","author":"Marr","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1053\/ajkd.2002.36332_bib87","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1046\/j.1523-1755.1998.00134.x","article-title":"Incidence and outcome of Staphylococcus aureus bacteremia in hemodialysis patients","volume":"54","author":"Marr","year":"1998","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2002.36332_bib88","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S0272-6386(99)70018-1","article-title":"Bacteremia associated with tunneled, cuffed hemodialysis catheters","volume":"34","author":"Saad","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.36332_bib89","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1681\/ASN.V1051045","article-title":"Management of bacteremia associated with tunneled-cuffed hemodialysis catheters","volume":"10","author":"Beathard","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2002.36332_bib90","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0272-6386(95)90129-9","article-title":"Catheter-related sepsis complicating long-term, tunnelled central venous dialysis catheters: Management by guidewire exchange","volume":"25","author":"Shaffer","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.36332_bib91","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1046\/j.1523-1755.1998.00954.x","article-title":"Treatment of infected tunneled venous access hemodialysis catheters with guidewire exchange","volume":"53","author":"Robinson","year":"1998","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2002.36332_bib92","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1046\/j.1523-1755.2000.00067.x","article-title":"Bacteremia associated with tunneled dialysis catheters: Comparison of two treatment strategies","volume":"57","author":"Tanriover","year":"2000","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2002.36332_bib93","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1177\/089686089601600606","article-title":"Peritoneal dialysis-related peritonitis treatment recommendations: 1996 Update","volume":"16","author":"Keane","year":"1996","journal-title":"Perit Dial Int"},{"key":"10.1053\/ajkd.2002.36332_bib94","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/089686089301300106","article-title":"Peritoneal dialysis-related peritonitis. Treatment recommendations: 1993 Update","volume":"13","author":"Keane","year":"1993","journal-title":"Perit Dial Int"},{"key":"10.1053\/ajkd.2002.36332_bib95","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1046\/j.1525-139x.2000.00107.x","article-title":"Indications for vancomycin in dialysis patients","volume":"13","author":"Golper","year":"2000","journal-title":"Semin Dial"},{"key":"10.1053\/ajkd.2002.36332_bib96","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1525-139X.1997.tb00472.x","article-title":"The treatment of CAPD peritonitis with vancomycin: The genesis of new clinical guidelines","volume":"10","author":"Vas","year":"1997","journal-title":"Semin Dial"},{"key":"10.1053\/ajkd.2002.36332_bib97","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1053\/ajkd.2001.20581","article-title":"Initial treatment of peritoneal dialysis peritonitis without vancomycin with a once-daily cefazolin-based regimen","volume":"37","author":"Goldberg","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.36332_bib98","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/089686089701700119","article-title":"Intraperitoneal once-daily dose of cefazolin and gentamicin for treating CAPD peritonitis","volume":"17","author":"Lai","year":"1997","journal-title":"Perit Dial Int"},{"key":"10.1053\/ajkd.2002.36332_bib99","first-page":"897","article-title":"Nosocomial infections associated with hemodialysis","author":"Favero","year":"1999"},{"key":"10.1053\/ajkd.2002.36332_bib100","first-page":"128","article-title":"Effects of \u201cisolating hemodialysis\u201d on prevention of methicillin-resistant Staphylococcus aureus cross-infection in a hemodialysis unit","volume":"54","author":"Osono","year":"2000","journal-title":"Clin Nephrol"},{"key":"10.1053\/ajkd.2002.36332_bib101","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0195-6701(98)90090-1","article-title":"Epidemiology and control of vancomycin-resistant enterococci (VRE) in a renal unit","volume":"40","author":"Brown","year":"1998","journal-title":"J Hosp Infect"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638602500263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638602500263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T21:08:46Z","timestamp":1622322526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638602500263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11]]},"references-count":101,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,11]]}},"alternative-id":["S0272638602500263"],"URL":"https:\/\/doi.org\/10.1053\/ajkd.2002.36332","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2002,11]]}}}